BEAM THERAPEUTICS INC. - COMMON STOCK

Beam Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

03 Jan 2022 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Outlines Long-term Strategy for Base Editing Programs in Sickle Cell Disease and Provides Preclinical Data Updates at ASH

12 Dec 2021 08:00:00 By Nasdaq GlobeNewswire

Beam Therapeutics Reports Preclinical Data Highlighting Multiplex Base Editing Approach to Create Anti-CD5 CAR T-cell Investigational Therapies for T-Cell Malignancies

12 Nov 2021 06:00:02 By Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the Jefferies 2021 Virtual London Healthcare Conference

11 Nov 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Appoints Healthcare Industry Leader John Maraganore, Ph.D., to its Board of Directors

08 Nov 2021 05:00:00 By Nasdaq GlobeNewswire

Beam Therapeutics Provides Business and Pipeline Updates and Reports Third Quarter 2021 Financial Results

08 Nov 2021 05:00:00 By Nasdaq GlobeNewswire

Beam Therapeutics Announces Upcoming Preclinical Data Presentations at the American Society of Hematology Annual Meeting

04 Nov 2021 08:40:00 By Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the Jefferies Gene Therapy/Editing Summit

20 Oct 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Announces Preclinical Data Highlighting Base Editing Approach to Correct a Glycogen Storage Disease Type Ia Disease-Causing Mutation

19 Oct 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics to Present Preclinical Data Highlighting Potential of CAR T Multiplex Base Editing Approach Targeting CD5 at 2021 SITC Annual Meeting

01 Oct 2021 07:43:59 By Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference

28 Sep 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Announces Updated Preclinical Data Highlighting Optimized LNP Delivery Approaches for In Vivo Base Editing to the Liver and Other Tissues

23 Sep 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the 2021 Wells Fargo Virtual Healthcare Conference

08 Sep 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Provides Business and Pipeline Updates and Reports Second Quarter 2021 Financial Results

10 Aug 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the 2021 Wedbush PacGrow Healthcare Conference

03 Aug 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the 2021 William Blair Biotech Focus Conference

08 Jul 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the 2021 Jefferies Virtual Healthcare Conference

25 May 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Presents LNP Formulation Data at ASGCT and Reports First Quarter 2021 Financial Results

11 May 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Announces Oral and Poster Presentations at 24th American Society of Gene and Cell Therapy Annual Meeting

27 Apr 2021 15:41:11 By Nasdaq GlobeNewswire

Beam Therapeutics Publishes Data Highlighting Ability to Rationally Design Base Editors for Precise Editing

20 Apr 2021 09:12:36 By Nasdaq GlobeNewswire